glp 1 results GLP-1/GIP After 1, 3, and 6 Months GLP-1 Weight Loss Injections in

GLP-1 microdosing may represent part of this evolution, offering a more nuanced approach to metabolic health optimization

911 Although these findings provide insight into the potential relationship between GLP-1RAs and cancer risk, all existing studies have focused on comparisons among glucose-lowering drugs (GLDs) in patients with T2D, leaving uncertainty regarding their potential role in cancer prevention in individuals with obesity regardless of diabetes status

JAMA Psychiat

Stevens B

A phase 2, 16-week, open-label study in 18 subjects ranging from 6 to 40 years of age results in a mean BMI reduction of 18% in those younger than 18 years, and 6% for those 18 years or older, accompanied by significant reduction of hunger scores (127)